Respiratory Infections News

In a new study, rates of all-cause mortality in the year after hospitalization for pneumonia were high and were associated with increasing age and a worse comorbidity profile, researchers reported in Respiratory Medicine.

An investigational respiratory syncytial virus vaccine was safe and effective against RSV-mediated lower respiratory tract disease among older adults, according to results from a phase 2 randomized controlled study called CYPRESS.

A team of researchers from Seattle and the CDC found that neutralizing antibodies remained detectable in most children 6 months after SARS-CoV-2 infection, waning “to a small degree,” according to results presented at IDWeek.

Several medical boards have announced that physicians who engage in “unethical or unprofessional conduct” regarding COVID-19 may be subject to disciplinary action.

A 3-day course of IV remdesivir was safe, well tolerated and prevented COVID-19-related hospitalizations among high-risk COVID-19 patients, according to data presented at IDWeek.

Unlike influenza and respiratory syncytial virus, which all but disappeared during their typical winter peaks, common cold viruses continued to circulate among children during the COVID-19 pandemic, according to researchers at IDWeek.

Numerous studies have shown that racial minority groups have been disproportionately affected by the COVID-19 pandemic. Experts at IDWeek said this has a lot do with history.

Nearly half of Black parents reported being hesitant to get their child vaccinated against COVID-19, according to survey results from researchers in Chicago.

Safety monitoring found “no unexpected patterns of adverse reactions” among thousands of Americans who have received a third dose of a COVID-19 messenger RNA vaccine, researchers reported in MMWR.

IDWeek, originally planned for San Diego, will be an all-virtual meeting for the second year in a row because of COVID-19.